Fig. 5From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosisChanges of SDF-1 and CXCR4 in group A and group B after chemotherapy. A After chemotherapy, the decrease of SDF-1 in group B was significantly higher than that in group A, a indicates P<0.001. B After chemotherapy, the decrease of CXCR4 in group B was significantly higher than that in group A, a indicates P<0.001Back to article page